Leptospirosis Incidence at Four Sites in Sub-Saharan Africa and South East Asia: An International Multi-Site Hybrid Surveillance Study
Issued Date
2026-03-01
Resource Type
eISSN
23288957
Scopus ID
2-s2.0-105033368416
Journal Title
Open Forum Infectious Diseases
Volume
13
Issue
3
Rights Holder(s)
SCOPUS
Bibliographic Citation
Open Forum Infectious Diseases Vol.13 No.3 (2026)
Suggested Citation
Crump J.A., Picardeau M., Ajanovic S.A., Bradley J., Bramugy J.M., Chimenya M., Green E.W., Lal S., Mabey D.C.W., Mayxay M., Newton P.N., Olaru I.D., Hopkins H., Bottomley C., Amos B., Ashley E.A., Baerenbold O., Baghoumina S., Balanza N., Bandason T., Bassat Q., Bhattacharyya T., Blacksell S.D., Boca Z., Chandler C.I.R., Chansamouth V., Chipanga J., Cossa A., Dauya E., Davis C., De Lamballerie X., Dixon J., Douangphachanh S., Dubot-Pérès A., Durkin M.M., Feasey N.A., Ferrand R.A., Fink C., Fitchett E.J.A., Gerada A., Graves S.R., Handley B.L., Hutchison C.D., Jaksuwan R., Jervis J., Jones J., Kain K.C., Keddie S.H., Khounpaseuth K., Kranzer K., Kunlaya K., Lal P., Lalloo D.G., Luangraj M., Lubell Y., MacPherson E., Makoga F., Manichan S., Marlais T., Maurer F., Miles M., Mogeni P., Mucasse C., Nguyen C., Phimolsarnnousith V., Roberts C.H., Sengduangphachanh A., Sengsavang S., Sibanda M., Singha S., Stenos J., Tanganuchitcharnchai A., Tanvir H., Ussher J.E., Valente M., Voice M.A., Vongsouvath M., Wamaka M., Wheat L.J., Yeung S. Leptospirosis Incidence at Four Sites in Sub-Saharan Africa and South East Asia: An International Multi-Site Hybrid Surveillance Study. Open Forum Infectious Diseases Vol.13 No.3 (2026). doi:10.1093/ofid/ofag021 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/115910
Title
Leptospirosis Incidence at Four Sites in Sub-Saharan Africa and South East Asia: An International Multi-Site Hybrid Surveillance Study
Author(s)
Crump J.A.
Picardeau M.
Ajanovic S.A.
Bradley J.
Bramugy J.M.
Chimenya M.
Green E.W.
Lal S.
Mabey D.C.W.
Mayxay M.
Newton P.N.
Olaru I.D.
Hopkins H.
Bottomley C.
Amos B.
Ashley E.A.
Baerenbold O.
Baghoumina S.
Balanza N.
Bandason T.
Bassat Q.
Bhattacharyya T.
Blacksell S.D.
Boca Z.
Chandler C.I.R.
Chansamouth V.
Chipanga J.
Cossa A.
Dauya E.
Davis C.
De Lamballerie X.
Dixon J.
Douangphachanh S.
Dubot-Pérès A.
Durkin M.M.
Feasey N.A.
Ferrand R.A.
Fink C.
Fitchett E.J.A.
Gerada A.
Graves S.R.
Handley B.L.
Hutchison C.D.
Jaksuwan R.
Jervis J.
Jones J.
Kain K.C.
Keddie S.H.
Khounpaseuth K.
Kranzer K.
Kunlaya K.
Lal P.
Lalloo D.G.
Luangraj M.
Lubell Y.
MacPherson E.
Makoga F.
Manichan S.
Marlais T.
Maurer F.
Miles M.
Mogeni P.
Mucasse C.
Nguyen C.
Phimolsarnnousith V.
Roberts C.H.
Sengduangphachanh A.
Sengsavang S.
Sibanda M.
Singha S.
Stenos J.
Tanganuchitcharnchai A.
Tanvir H.
Ussher J.E.
Valente M.
Voice M.A.
Vongsouvath M.
Wamaka M.
Wheat L.J.
Yeung S.
Picardeau M.
Ajanovic S.A.
Bradley J.
Bramugy J.M.
Chimenya M.
Green E.W.
Lal S.
Mabey D.C.W.
Mayxay M.
Newton P.N.
Olaru I.D.
Hopkins H.
Bottomley C.
Amos B.
Ashley E.A.
Baerenbold O.
Baghoumina S.
Balanza N.
Bandason T.
Bassat Q.
Bhattacharyya T.
Blacksell S.D.
Boca Z.
Chandler C.I.R.
Chansamouth V.
Chipanga J.
Cossa A.
Dauya E.
Davis C.
De Lamballerie X.
Dixon J.
Douangphachanh S.
Dubot-Pérès A.
Durkin M.M.
Feasey N.A.
Ferrand R.A.
Fink C.
Fitchett E.J.A.
Gerada A.
Graves S.R.
Handley B.L.
Hutchison C.D.
Jaksuwan R.
Jervis J.
Jones J.
Kain K.C.
Keddie S.H.
Khounpaseuth K.
Kranzer K.
Kunlaya K.
Lal P.
Lalloo D.G.
Luangraj M.
Lubell Y.
MacPherson E.
Makoga F.
Manichan S.
Marlais T.
Maurer F.
Miles M.
Mogeni P.
Mucasse C.
Nguyen C.
Phimolsarnnousith V.
Roberts C.H.
Sengduangphachanh A.
Sengsavang S.
Sibanda M.
Singha S.
Stenos J.
Tanganuchitcharnchai A.
Tanvir H.
Ussher J.E.
Valente M.
Voice M.A.
Vongsouvath M.
Wamaka M.
Wheat L.J.
Yeung S.
Author's Affiliation
Universitat de Barcelona
University of Glasgow
University of Toronto Faculty of Medicine
University of Warwick
University of Otago
London School of Hygiene & Tropical Medicine
University Health Network
Institut Pasteur, Paris
Institució Catalana de Recerca i Estudis Avançats
Nuffield Department of Medicine
Toronto General Hospital
Liverpool School of Tropical Medicine
Instituto de Salud Global de Barcelona
Forschungszentrum Borstel - Zentrum für Medizin und Biowissenschaften
Mahidol Oxford Tropical Medicine Research Unit
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Ministry of Health Malawai
Institut Pasteur de Dakar
Centro de Investigação em Saúde de Manhiça CISM
Émergence des Pathologies Virales
Biomedical Research and Training Institute Harare
Mahosot Hospital, Lao
University Hospital Geelong
MiraVista Diagnostics
Liverpool Clinical Laboratories
Awanui Laboratories
Vientiane Provincial Hospital
UHS
University of Glasgow
University of Toronto Faculty of Medicine
University of Warwick
University of Otago
London School of Hygiene & Tropical Medicine
University Health Network
Institut Pasteur, Paris
Institució Catalana de Recerca i Estudis Avançats
Nuffield Department of Medicine
Toronto General Hospital
Liverpool School of Tropical Medicine
Instituto de Salud Global de Barcelona
Forschungszentrum Borstel - Zentrum für Medizin und Biowissenschaften
Mahidol Oxford Tropical Medicine Research Unit
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Ministry of Health Malawai
Institut Pasteur de Dakar
Centro de Investigação em Saúde de Manhiça CISM
Émergence des Pathologies Virales
Biomedical Research and Training Institute Harare
Mahosot Hospital, Lao
University Hospital Geelong
MiraVista Diagnostics
Liverpool Clinical Laboratories
Awanui Laboratories
Vientiane Provincial Hospital
UHS
Corresponding Author(s)
Other Contributor(s)
Abstract
Background There are few leptospirosis incidence studies despite such estimates being central to accurate burden of disease estimation. We used data from the multicenter Febrile Illness Evaluation in a Broad Range of Endemicities (FIEBRE) study to make leptospirosis incidence estimates from new sites. Methods Febrile patients aged ≥2 months in Laos, Malawi, Mozambique, and Zimbabwe were enrolled and underwent standardized clinical and exposure assessment. Acute and convalescent sera were tested by Leptospira microscopic agglutination test and acute plasma by lfb1 polymerase chain reaction (PCR). Participants with ≥4-fold rise in antibody titer between acute and convalescent sample, or Leptospira PCR positive for the lfb1, had confirmed leptospirosis. Leptospirosis incidence was estimated after adjusting for incomplete enrollment of febrile patients, availability of paired sera, and use of study healthcare facilities by febrile patients based on healthcare utilization data from community controls. Results Leptospirosis incidence (95% CI) per 100 000 population per year was 1302 (1011, 1677) in Laos, 1337 (874, 2044) in Malawi, 187 (85, 409) in Mozambique, and could not be calculated for Zimbabwe. Sensitivity analysis restricted to pre-COVID years of 2018 and 2019 produced similar estimates of incidence to that of the whole study period. Conclusions Leptospirosis incidence was high at the Laos, Malawi, and Mozambique sites and at the upper end of published incidence estimates from the Asia and Africa regions. We recommend more leptospirosis incidence studies be done in areas lacking data to strengthen leptospirosis global burden of disease estimates and to stimulate progress on diagnosis, management, and control.
